- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
834
Companies which are more than 50% undervalued based on analyst price target.
834 companies
Acurx Pharmaceuticals
Market Cap: US$8.5m
A clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States.
ACXP
US$0.36
7D
-12.8%
1Y
-82.3%
Silexion Therapeutics
Market Cap: US$8.4m
A biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors.
SLXN
US$0.98
7D
-1.5%
1Y
-99.0%
iBio
Market Cap: US$8.2m
A preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases.
IBIO
US$0.77
7D
-23.4%
1Y
-58.2%
Turnstone Biologics
Market Cap: US$8.1m
Operates as a biotechnology company.
TSBX
US$0.34
7D
-2.9%
1Y
-88.9%
HCW Biologics
Market Cap: US$8.0m
A clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States.
HCWB
US$6.18
7D
-19.0%
1Y
-86.3%
NextCell Pharma
Market Cap: SEK 77.9m
A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.
NXTCL
SEK 1.07
7D
-6.2%
1Y
-15.1%
Brainstorm Cell Therapeutics
Market Cap: US$8.0m
A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.
BCLI
US$1.18
7D
-6.3%
1Y
-82.7%
Biovica International
Market Cap: SEK 75.9m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America.
BIOVIC B
SEK 0.78
7D
-3.0%
1Y
-52.4%
TME Pharma
Market Cap: €6.9m
A clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany.
ALTME
€0.073
7D
15.9%
1Y
-71.1%
Mainz Biomed
Market Cap: US$7.7m
Develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe.
MYNZ
US$2.45
7D
-13.9%
1Y
-90.7%
Oncodesign Precision Medicine Société anonyme
Market Cap: €6.7m
A biopharmaceutical company, engages in the precision medicine business.
ALOPM
€0.37
7D
0%
1Y
-73.8%
Aytu BioPharma
Market Cap: US$7.5m
A pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally.
AYTU
US$1.25
7D
-4.6%
1Y
-61.8%
Citius Pharmaceuticals
Market Cap: US$7.4m
A biopharmaceutical company, focuses on the development and commercialization of critical care products.
CTXR
US$0.75
7D
-2.5%
1Y
-95.7%
Alligator Bioscience
Market Cap: SEK 70.2m
A research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Finland and Sweden.
ATORX
SEK 4.15
7D
-1.1%
1Y
-99.5%
AcouSort
Market Cap: SEK 67.9m
A technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies.
ACOU
SEK 3.21
7D
-20.5%
1Y
-69.9%
Genprex
Market Cap: US$6.9m
A clinical-stage gene therapy company, focuses on developing gene-based therapies for patient populations with unmet medical needs.
GNPX
US$0.29
7D
-1.6%
1Y
-87.7%
Newbury Pharmaceuticals
Market Cap: SEK 66.7m
Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.
NEWBRY
SEK 2.75
7D
-14.3%
1Y
-15.9%
Addex Therapeutics
Market Cap: CHF 5.7m
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland.
ADXN
CHF 0.058
7D
-1.7%
1Y
-20.5%
Curasight
Market Cap: DKK 44.4m
A biotech company, develops treatment of cancer.
CURAS
DKK 2.10
7D
-7.5%
1Y
-80.0%
Evoke Pharma
Market Cap: US$6.7m
Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.
EVOK
US$3.14
7D
1.6%
1Y
-43.2%
Spago Nanomedical
Market Cap: SEK 64.8m
A clinical phase nanomedicine company, engages in the development of nanomedicines for cancer diagnostics and treatment primarily in Sweden.
SPAGO
SEK 0.19
7D
0.3%
1Y
-37.8%
Theracryf
Market Cap: UK£5.0m
A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioral brain disorders.
TCF
UK£0.0024
7D
0%
1Y
-68.7%
Acrux
Market Cap: AU$10.2m
Engages in the development and commercialization of generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally.
ACR
AU$0.025
7D
8.7%
1Y
-60.9%
Biofrontera
Market Cap: US$6.5m
A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
BFRI
US$0.69
7D
-3.5%
1Y
-44.8%
Lyra Therapeutics
Market Cap: US$6.3m
A clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis.
LYRA
US$0.098
7D
-9.3%
1Y
-73.6%
Soligenix
Market Cap: US$6.2m
A late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States.
SNGX
US$1.98
7D
2.9%
1Y
-69.0%
Lipella Pharmaceuticals
Market Cap: US$6.2m
A clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications.
LIPO
US$2.40
7D
-4.6%
1Y
-59.0%
Indaptus Therapeutics
Market Cap: US$6.2m
A clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products.
INDP
US$0.40
7D
-12.9%
1Y
-81.4%
MetaVia
Market Cap: US$6.1m
A clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases.
MTVA
US$0.73
7D
-6.4%
1Y
-81.6%
GT Biopharma
Market Cap: US$5.9m
A clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) fusion protein immune cell engager technology platforms.
GTBP
US$2.27
7D
-2.6%
1Y
-31.7%
Jaguar Health
Market Cap: US$5.9m
A commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress.
JAGX
US$8.51
7D
-34.4%
1Y
-98.1%
Delivra Health Brands
Market Cap: CA$7.3m
Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.
DHB
CA$0.19
7D
11.8%
1Y
-57.8%
ExpreS2ion Biotech Holding
Market Cap: SEK 51.0m
Through its subsidiary, ExpreS2ion Biotechnologies ApS, researches and develops preventive and therapeutic vaccine products in the Nordics and internationally.
EXPRS2
SEK 19.20
7D
0.6%
1Y
-67.3%
Sonoma Pharmaceuticals
Market Cap: US$5.2m
Develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye and nasal care, oral care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.
SNOA
US$3.15
7D
-6.8%
1Y
8.2%
OncoZenge
Market Cap: SEK 49.2m
A pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden.
ONCOZ
SEK 4.20
7D
-1.9%
1Y
6.2%
Theranexus Société Anonyme
Market Cap: €4.3m
A biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders.
ALTHX
€0.55
7D
25.3%
1Y
-50.9%